Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease

Intranasal delivery provides a practical, non-invasive method of bypassing the blood-brain barrier (BBB) to deliver therapeutic agents to the brain and spinal cord. This technology allows drugs that do not cross the BBB to be delivered to the central nervous system within minutes. It also directly d...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanson, Leah R, Frey, William H
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2604883/
https://www.ncbi.nlm.nih.gov/pubmed/19091002
http://dx.doi.org/10.1186/1471-2202-9-S3-S5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2604883/
https://www.ncbi.nlm.nih.gov/pubmed/19091002
http://dx.doi.org/10.1186/1471-2202-9-S3-S5

Ejemplares similares